Form 8-K GW PHARMACEUTICALS PLC For: May 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
GW Pharma (GWPH) PT Raised to $200 at Cowen
May 7, 2019 6:43 AM EDTCowen analyst Phil Nadeau raised the price target on GW Pharma (NASDAQ: GWPH) to $200.00 (from $175.00) while maintaining a Outperform rating following results.
The analyst commented, "GW reported $33.5MM in Epidiolex revenue during its first full quarter on the market, well ahead of consensus... More
GW Pharma (GWPH) PT Raised to $229 at Cantor Fitzgerald
May 7, 2019 6:42 AM EDTCantor Fitzgerald analyst Elemer Piros raised the price target on GW Pharma (NASDAQ: GWPH) to $229.00 (from $196.00) while maintaining a Overweight rating following Q1 results.
Piros commented, "The company reported the first full quarter of EPIDIOLEX revenues of $33.5 million. Additionally, GWPH reported positive... More
